Description for AOD 9604 5mg Peptide.

AOD 9604 5mg Peptide – The Lipolytic Fragment Unlocking Selective Fat Metabolism Research

What if a precisely engineered 16-amino-acid peptide, derived from the C-terminal region of human growth hormone, could trigger targeted lipolysis, enhance fat oxidation, reduce adipose accumulation, and potentially support cartilage repair mechanisms—all in preclinical models without significantly affecting IGF-1 levels, glucose homeostasis, or the broader hormonal cascade normally associated with full-length GH? This is the compelling, highly selective metabolic profile that continues to drive interest in AOD 9604 5mg Peptide, the synthetic hGH fragment that's long been a key research tool in obesity, lipid metabolism, body composition, and regenerative orthopedics studies.

At Cali BioLab Peptides, AOD 9604 5mg Peptide is supplied as a sterile, high-purity (≥99%) lyophilized powder in a 5mg research vial—third-party HPLC/MS verified, batch-specific Certificates of Analysis included, and shipped fast within the USA. This compact 5mg format is ideal for dose-response curves, acute or short-term animal protocols, cell culture experiments, or pilot studies exploring fat metabolism and tissue repair pathways.

Strict Disclaimer: For laboratory and scientific research use only. Not for human consumption, therapeutic, diagnostic, veterinary, or any non-research application. Strictly intended for qualified researchers conducting in-vitro, ex-vivo, or ethically approved animal model studies. Cali BioLab Peptides maintains full regulatory compliance.

The Obesity Reversal Model That Highlighted Selective Fat Loss: Dr. Neha’s DIO Mouse Study

In a metabolic research group at a leading Australian university, Dr. Neha Patel was investigating diet-induced obesity (DIO) in C57BL/6 mice fed a 60% high-fat diet for 12 weeks. Her animals developed severe adiposity, insulin resistance, elevated hepatic triglycerides, reduced energy expenditure, and persistent weight gain despite caloric restriction attempts.

Direct GH administration caused unwanted IGF-1 elevation and glucose dysregulation; calorie restriction alone was insufficient for selective fat loss. Neha had followed early Australian studies on AOD9604's lipolytic domain and ordered AOD 9604 5mg Peptide from Cali BioLab Peptides. The 5mg vial arrived lyophilized with a COA confirming 99.4% purity.

In her 8-week intervention, Neha administered subcutaneous AOD 9604 5mg Peptide (~250–500 μg/kg daily). The results were striking: treated DIO mice showed significant reductions in body fat mass (DEXA), decreased adipocyte size (histology), increased lipolysis markers (HSL phosphorylation), improved lipid profiles (lower triglycerides), enhanced energy expenditure (indirect calorimetry), and accelerated weight loss—without measurable changes in circulating IGF-1, glucose intolerance, or lean mass loss. Liver fat content also decreased markedly in a subset with steatosis.

Neha’s publication in a respected metabolism journal demonstrated that AOD 9604 5mg Peptide could selectively promote fat metabolism and body composition improvement in obesity models without the endocrine side effects of intact GH. The study attracted new funding and collaborations focused on targeted lipolytic peptides. The AOD 9604 5mg Peptide became a staple in her group’s obesity reversal and adipose biology research.

What Exactly Is AOD 9604 5mg Peptide?

AOD 9604 5mg Peptide (Anti-Obesity Drug 9604) is a synthetic 16-amino-acid peptide fragment corresponding to residues 177–191 of the C-terminal region of human growth hormone (hGH). It was developed to retain the lipolytic (fat-burning) domain of hGH while eliminating most of the growth-promoting, IGF-1-stimulating, and diabetogenic effects of the full hormone.

Key product specifications:

• Quantity: 5mg sterile lyophilized powder per vial—ideal for pilot studies, dose-finding, or short-term protocols
• Purity: ≥99% (third-party verified by HPLC and Mass Spectrometry)
• Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-Tyr (hGH 177–191 fragment)
• Molecular Formula: C₇₈H₁₂₃N₂₃O₂₃S₂
• Molecular Weight: ≈1815.1 Da
• CAS Number: 221231-10-3
• Form: White lyophilized powder
• Storage: –20 °C long-term; 2–8 °C after reconstitution with bacteriostatic water or PBS
• COA: Batch-specific analytical report included

In research settings, AOD 9604 5mg Peptide is primarily studied for its selective stimulation of lipolysis in adipose tissue without significantly activating the IGF-1 axis or altering glucose metabolism.

How AOD 9604 5mg Peptide Works in Biological Systems

AOD 9604 5mg Peptide mimics the lipolytic domain of hGH by:

• Binding to and activating adipocyte receptors → stimulating hormone-sensitive lipase (HSL) → breaking down triglycerides into free fatty acids and glycerol
• Enhancing β-oxidation in adipose and liver tissue
• Reducing de novo lipogenesis and fat accumulation
• Potentially supporting cartilage matrix synthesis (via chondrocyte stimulation in some models) without full GH-like growth promotion

Unlike full hGH, AOD 9604 5mg Peptide shows minimal impact on IGF-1 production, glucose uptake, or insulin sensitivity in most studies, making it a cleaner probe for fat-specific metabolic research.

Research Applications of AOD 9604 5mg Peptide

AOD 9604 5mg Peptide is applied in:

• Diet-induced obesity (DIO) and weight-loss reversal models
• Selective lipolysis and fat oxidation studies (indirect calorimetry, HSL activity)
• Adipocyte metabolism and lipid droplet dynamics
• Cartilage repair and osteoarthritis analogs (chondrocyte proliferation, matrix synthesis)
• Metabolic syndrome and insulin resistance models (with focus on fat-specific effects)
• Comparative studies vs. full hGH or other lipolytic agents

Key research endpoints:

• Reduction in body fat mass & adipocyte size (DEXA, histology)
• Increased lipolysis markers (glycerol release, HSL phosphorylation)
• Improved lipid profiles (triglycerides, free fatty acids)
• Enhanced energy expenditure and fat oxidation
• Cartilage matrix production (GAGs, collagen II) in joint models
• Preservation of lean mass during weight loss

Usage and Reconstitution Guidelines for AOD 9604 5mg Peptide

1. Allow vial to reach room temperature.
2. Add 1–2 mL bacteriostatic water or sterile PBS; gently swirl.
3. Prepare stock solutions (e.g., 5 mg/mL) and dilute for working concentrations (typically 100–500 μg/kg in vivo or μg/mL in vitro).
4. Aliquot immediately → store at –80 °C. Thawed aliquots stable 2–8 °C for days.

Common routes: subcutaneous or intraperitoneal injection in animal models; direct addition to adipocyte or chondrocyte culture media.

Frequently Asked Questions About AOD 9604 5mg Peptide

Q: How does AOD 9604 5mg Peptide differ from full human growth hormone (hGH) in research models? A: AOD 9604 5mg Peptide retains the lipolytic domain of hGH but lacks significant IGF-1 stimulation, glucose dysregulation, or growth-promoting effects—making it a more targeted tool for fat metabolism and cartilage studies.

Q: What dosing ranges are common in preclinical literature? A: In-vivo studies typically use 100–500 μg/kg (subcutaneous or IP); in-vitro concentrations often 1–100 μg/mL in adipocytes or chondrocytes.

Q: Is AOD 9604 5mg Peptide stable after reconstitution? A: Yes—stable for weeks refrigerated when aliquoted; freeze for longer storage.

Q: Can it be used in cartilage or joint repair models? A: Yes—preclinical data suggest benefits in chondrocyte proliferation and matrix synthesis for osteoarthritis analogs.

Q: How to verify batch quality? A: Match the provided COA on the product page.

One Question That Could Shape Your Next Metabolic or Regenerative Study

If you could deploy AOD 9604 5mg Peptide right now in an obesity or cartilage degeneration model, which mechanism—selective lipolysis, fat oxidation enhancement, or chondrocyte matrix stimulation—would you prioritize first, and what key metabolic or histological endpoint would you measure to demonstrate efficacy?

Your answer might become the foundation of your next high-impact publication.

In summary, AOD 9604 5mg Peptide from Cali BioLab Peptides is a selective, lipolytic hGH fragment with compelling preclinical potential in fat metabolism, body composition, and cartilage repair research. With exceptional purity, reliable supply, and strong evidence from obesity and joint models, it's ready to advance your 2026 investigations into targeted metabolic and regenerative pathways.

Order your AOD 9604 5mg Peptide today at Cali BioLab Peptides and explore selective fat loss and tissue support with precision and confidence.